問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberD8210C00003
Completed

2023-10-01 - 2026-12-31

Phase II

Recruiting10

ICD-10J45.20

Mild intermittent asthma, uncomplicated

ICD-10J45.30

Mild persistent asthma, uncomplicated

ICD-10J45.40

Moderate persistent asthma, uncomplicated

ICD-10J45.50

Severe persistent asthma, uncomplicated

ICD-10J45.909

Unspecified asthma, uncomplicated

ICD-9493.00

Extrinsic asthma without mention of status asthmaticus

  • Trial Applicant

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/04/01

Investigators and Locations

Principal Investigator Chau-Chyun Sheu Division of Thoracic Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Pai-Chien Chou Division of Thoracic Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Ming -Cheng Chan Division of Thoracic Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Chung-Yu Chen Division of Thoracic Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 沈聲燁 Division of Thoracic Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator KUANG-YAO YANG Division of Thoracic Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Chih-Hsin Lee Division of Thoracic Medicine

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 李世偉 Division of Thoracic Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Jung-Yien Chien Division of Thoracic Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    13 participants

  • Global

    320 participants